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ABSTRACT 
The studies reported herein were undertaken to investigate 
the role of calcium and cyclic nucleotides as second 
messengers in the stimulation of endogenous pyrogen 
production from rabbit monocytes by bacterial endotoxin. 
We found that monocytes stimulated with endotoxin 
produced endogenous pyrogen, even under conditions of high 
or low extracellular calcium concentrations. Maximal 
production occurred when the calcium concentration was in 
the near-physiological range. Prolonged incubation of cells 
with a calcium chelator prevented subsequent activation with 
endotoxin, an effect which was rapidly reversible by 
readdition of calcium, but not other cations. Addition of 
small amounts of lanthanum, a blocker of membrane calcium 
channels, to cells prevented this reversal by subsequent 
calcium addition. New cell separation techniques were 
developed to obtain monocyte-enriched samples for study of 
calcium fluxes. Incorporation of a calcium ionophore into 
the cell membrane resulted in calcium influx, but did not 
stimulate pyrogen production. Further, no measurable influx 
or efflux of calcium occurred during stimulation of 
mononuclear cells with endotoxin. These observations 
suggest that a slowly-exchangeable calcium pool was 
11 

necessary for the production of endogenous pyrogen, but that 
a rise in intracellular calcium by itself was not a 
necessary or sufficient stimulus. Thus, calcium cannot be 
considered a second messenger in this system. 
Incubation of cells with agents shown to increase cyclic 
3', 5' AMP or cyclic 3', 5' GMP levels in monocytes 
similarly did not stimulate pyrogen production or modulate 
its production during endotoxin stimulation. Therefore, 
cyclic nucleotides do not act as second messengers in the 
derepression of the endogenous pyrogen genome either. 
Given the widespread production of endogenous pyrogen by 
nearly all vertebrates and the major role that the 
endogenous pyrogen/interleukin-1 molecule plays in 
controlling the immune response, further work should be 
undertaken to define the mechanism for its production more 
clearly. Suggestions for such future areas of investigation 
are discussed. 
- iii - 
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INTRODUCTION 
Ancient physicians recognized a close association 
between inflammation and elevated body temperature. So 
regular was this association that Celsus, a physician of the 
early Roman Empire, considered heat a cardinal sign of 
inflammation, along with its sister features of swelling, 
pain, and redness. 
The nature of the link between fever and inflammation, 
however, was hidden for many centuries by the Greek doctrine 
developed by Empedocles in the fifth century B.C. of four 
fundamental elements and their corresponding forms in the 
body, the humors. Humoral theory maintained that health 
depended upon a proper balance of blood, phlegm, black bile, 
and yellow bile in the body, and that fever indicated an 
excess of yellow bile, the physiological equivalent of fire. 
This Hippocratic tradition was continued by Galen who 
developed a full system of anatomy and physiology based upon 
it in the second century A.D. These concepts withstood all 
challenges until Harvey's demonstration of a closed 
circulatory system with rapid mixing of blood from all parts 
of the body made them untenable in the seventeenth century. 
Freed from the bias of this long-standing dogma, physicians 




hypotheses relied upon the heat generated by friction and 
fermentation (reviewed in 1). 
The first experimental attempts to explain the link 
between inflammation and fever, however, were reported 
independently in the nineteenth century by Weber (2) and 
Billroth (3) who showed that animals injected with pus from 
draining wounds became febrile. They did not assess the 
potential pyrogenicity of the agents responsible for pus 
formation, however. Welch later postulated that exogenous 
agents induced fever indirectly through the generation of a 
product by host leukocytes (4). In 1943 Menkin presented 
the first experimental evidence for such a product (5), a 
euglobulin he named pyrexin. He later crystallized this 
agent and defined its biological properties (6-8), but other 
investigators have shown that its characteristics were 
almost identical to those of bacterial endotoxin (9). This 
suggests that pyrexin may have been a modified form of 
endotoxin or that it relied upon contamination with 
endotoxin for its biological activity. 
Beeson reported the isolation of a pyrogen from 
polymorphonuclear leukocytes (PMN's) in 1948 (10). In later 
work with Bennett he showed that the biological properties 
of this leukocytic pyrogen (LP) differed from those of 
pyrexin and endotoxin (9, 11). Subsequently, Atkins and 
Wood demonstrated that rabbits made febrile by injection 
with typhoid vaccine had a transferable circulating pyrogen 
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which appeared in their bloodstream after clearance of the 
injected vaccine. The characteristics of this endogenous 
pyrogen (EP) were similar to those described by Bennett and 
Beeson for LP (12, 13). 
While early work indicated that PMN's produced EP, in 
1967 human blood monocytes (14), rabbit peritoneal 
macrophages (15), and rabbit alveolar macrophages (16) were 
all shown to be potent sources of EP. Other mononuclear 
phagocytic cells (MNPC’s), including human synovial exudate 
macrophages (17) and rabbit Kupffer cells (18, 19), produce 
EP, and there is recent evidence that keratinocytes do so, 
as well (20). With the development of efficient cell 
separation techniques it has been possible to show that 
PMN's do not, in fact, secrete EP, and it is likely that all 
EP production attributed to them in prior work was due to 
the presence of small numbers of MNPC's "contaminating" the 
culture conditions (21). 
The chemical nature of EP has been investigated 
extensively over the past thirty years, and the results of 
these studies have been reviewed in detail by Dinarello and 
Wolff (22). EP is a small protein or polypeptide with a 
molecular weight of 15,000 daltons. A 40,000 dalton pyrogen 
has also been described which may be a trimer of the smaller 
protein. Pyrogenicity is destroyed by heat or protease 
treatment, but it resists extraction with organic solvents. 
The portion of EP responsible for its pyrogenicity seems to 
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be common to several species, as EP from many species will 
produce a febrile response in others. Small species-defined 
differences exist, however, and have allowed the preparation 
of rabbit antibodies to human EP (23) and of goat antibodies 
to rabbit EP (24). Considerable evidence indicates that EP 
is identical to another MNPC product which stimulates T 
lymphocyte proliferation and activity, lymphocyte activating 
factor (LAF) (24, 25). These molecules are collectively 
referred to as Interleukin-1 (11-1). 
What is known about the pathogenesis of fever in 
homeotherms is summarized in Figure 1. Unstimulated cells 
do not release EP in culture, and no preformed EP can be 
demonstrated within them when they are physically disrupted 
(26, 27). Agents shown to stimulate EP release from MNPC's 
in vitro include heat-killed bacteria (16, 28), products of 
bacterial cell walls (29-32), viruses (33), crystals of 
urate and silica (34), and lymphokines released from T 
lymphocytes activated by antigens (35, 36) or mitogens (37). 
Circulating EP acts upon the body's thermoregulatory center 
located in the preoptic regions of the anterior hypothalamus 
(PO/AH) to increase body temperature by both reducing heat 
loss and increasing heat production (38). There is recent 
evidence that hyperthermia augments the proliferation of 
activated T lymphocytes, as well, thus making the effects of 
EP (or 11-1) on immunoregulation even more potent (39). 
Poikilotherms also produce EP, and they react to its 
presence by seeking a warmer ambient environment (40). 
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Inhibitors of DNA transcription, such as Actinomycin D, 
and inhibitors of RNA translation, such as puromycin and 
cyclohexamide, prevent EP release when added to MNPC's 
within two hours after addition of known stimuli (41, 42). 
As further evidence that EP release requires de novo 
synthesis, MNPC's incubated with stimuli in the presence of 
radioactively-labeled amino acids release EP which carries 
the label (43). 
Together these observations suggest that EP is an 
inducible protein, and that its production is repressed in 
the unstimulated MNPC. The mechanism by which known stimuli 
of EP production cause derepression of the EP genome, with 
subsequent transcription into mRNA and translation into 
protein, remains unknown. Figure 2 summarizes the available 
information concerning the mechanism involved. Phagocytosis 
does not appear to be necessary to the process, since 
incubation of MNPC's with cytochalasin B (44) or colchicine 
(45) in quantities sufficient to prevent phagocytosis does 
not prevent EP production. While corticosteroids inhibit EP 
production in vitro, specific cyclooxygenase inhibitors do 
not (46). Consistent with these findings, recent evidence 
suggests that lipoxygenase inhibitors prevent EP production 
(47). Thus, prostaglandins (PG's) do not appear to be 
important in generating EP, but leukotrienes (LT's) may play 
a role. There is no evidence that exogenous LT's are a 
sufficient stimulus to generate EP production, however. 
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Wood and his colleagues reported several years ago that 
rabbit peritoneal exudate (PE) cells released EP 
"spontaneously" when incubated in saline, but were inactive 
if incubated in plasma. By altering the composition of the 
incubation medium used they showed that the presence of 
potassium (K+) or calcium (Ca2+) in the extracellular fluid 
had an inhibitory effect on EP release (48-50). On the 
basis of cell-associated ion measurements they postulated 
that PE cells released EP as a response to K+ depletion. 
Thus, replenishing the cells with extracellular K+ would 
remove the stimulus to release EP. In further support of 
this hypothesis they reported that incubating cells with 
ouabain, an inhibitor of the sodium-potassium pump, allowed 
continued EP release in the presence of extracellular K+, 
presumably by preventing cellular uptake of the added K+. 
They proposed that Ca2+, on the other hand, exerted its 
inhibitory effect on EP release by altering the cell 
membrane in such a way as to make the cell unresponsive to 
K+ depletion (50). 
While this work presents an interesting hypothesis for 
the intracellular mechanism of EP production, the 
experimental system imposes several limitations upon its 
usefulness, some of which were acknowledged by the authors. 
First, study of the release of EP from cells which were 
already producing it cannot be used to elucidate the 
mechanism by which EP production is induced. In this 

9 
system, for example, EP release did not require protein 
synthesis (49). Second, at the time of those experiments 
PMN's were thought to be the primary source of EP. 
Consequently, the PE cells used were primarily PMN's, and 
measurements of cell-associated ions were, therefore, 
largely influenced by the ion content of the PMN's present. 
MNPC's, the cells actually responsible for EP production, 
were present in smaller and variable amounts. This may 
explain the authors' inability to show any direct 
correlation between cellular Na+ or K+ levels and EP 
production. Third, more recent attempts to recreate this 
system of "spontaneously" active PE cells have been 
unsuccessful, making further research on the system 
difficult. It is possible that the unidentified 
macromolecular activator of cells they described in exudate 
fluid was endotoxin (50). Due to the design of their 
system, it is not possible to exclude contamination of the 
ouabain used with endotoxin, as well. Fourth, in vitro 
incubation of stimulated blood leukocytes in the presence of 
physiological levels of Ca2+ and K+ does not prevent EP 
release (51) . 
White and Petersdorf attempted to extend these findings 
using an in vivo system (52). They found that rabbits made 
acutely or chronically hypokalemic produced more EP in 
response to a standard dose of heat-killed bacteria than did 
normal rabbits. Hyperkalemia with concurrent hypercalcemia. 
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however, did not reduce EP production from control levels. 
Unfortunately, the complexity of an in vivo system makes it 
difficult to change a single physical parameter without 
producing countless other changes designed to maintain a 
homeostatic balance. It is clear, however, that any 
inhibitory effect of Ca2 + or K+ on EP production was a 
relative one, not an absolute one as Wood's work suggested. 
In more recent years research in many diverse 
biological systems has shown an almost universal role for 
Ca2+, alone or in conjunction with cyclic nucleotides, as a 
second messenger for stimulus-secretion coupling (53). 
While there have been attempts to establish such a role for 
second messengers in the activation of MNPC's, the evidence 
has been fragmentary and sometimes contradictory. 
Several investigators have used the ionophore A23187 as 
a tool to investigate the importance of Ca2+ in MNPC 
activation. There have been reports that A23187 does (54) 
and does not (55) stimulate lysosomal enzyme secretion. In 
another study alveolar macrophages incubated with A23187 
demonstrated an increased rate of intracellular 
bacteriocidal activity and a rise in intracellular acid 
phosphatase when magnesium (Mg2+) was included in the 
incubation medium. No such effect was seen with Ca2+, 
however (56). 
Adenosine 3', 5' cyclic monophosphate (cAMP) has been 
reported to inhibit macrophage migration (57), to decrease 
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secretion of plasminogen activator by mouse PE cells (58) 
and a macrophage-like tumor cell line (J774.2) (59), and to 
decrease the secretion of lysosomal enzymes by mouse PE 
cells (60). Others have shown that guanosine 3', 5' cyclic 
monophosphate (cGMP) either decreases (61) or increases (62) 
human monocyte chemotaxis, but does not affect the response 
of macrophages to a lymphokine, macrophage inhibitory factor 
(MIF) (57). There is a brief report that isobutyl-methyl- 
xanthine (IBMX), a phosphodiesterase inhibitor which should 
increase endogenous levels of both cAMP and cGMP, does not 
stimulate or modulate EP production by human monocytes (63). 
However, no attempt has been made to manipulate selectively 
the cAMP or cGMP concentration in MNPC's to assess its role 
in EP production. 
Given the diverse nature of known stimulators of EP 
production, ranging from inorganic urate crystals to 
biological products of stimulated lymphocytes, it seems 
reasonable that some common pathway exists within the MNPC 
which is responsible for derepression of the EP genome. The 
studies reported herein were undertaken to investigate the 
role of Ca2+ and/or cyclic nucleotides as second messengers 
in this process. 

MATERIALS AND METHODS 
General 
All glassware was sterilized by dry heat at 180°C for two 
hours to inactivate any pyrogenic contaminants. All 
reagents were demonstrated to be pyrogen-free by their 
inability to stimulate EP production from buffy coat 
monocytes in vitro. Samples from all blood and incubation 
supernatants were found to be sterile by culture for at 
least three days at 37°C in thioglycollate broth. Except as 
noted, all media and reagents were stored at 2°C. 
Incubation Media 
Most incubations were performed in Hank's balanced salt 
solution (HBSS) prepared from a 10X concentrate without 
calcium, magnesium, or bicarbonate (GIBCO). Some 
experiments were carried out in Eagle's minimum essential 
medium (MEM) which contained calcium and magnesium (Flow 
Labs). Both media were supplemented with 1.96 g/1 sodium 






Boivin extracted endotoxin from E. coli 0127.B8 (LPS, Difco 
Laboratories) was prepared as a stock solution of 5 mg/ml in 
sterile saline (Abbott Laboratories) and diluted to a 
working solution of 1 ng/ml in saline (for MEM incubations) 
or in HBSS before each use. 
CaCl2.2H20, MgCl2.6H20 (Certified Grade, Fisher 
Scientific), LaCl3.7H20 (Aldrich Chemicals), and ethylene- 
glycol-bis-(B-amino-ethyl ether) N,N' tetra-acetic acid 
(EGTA, Sigma Chemical Co.) were sterilized by dry heat at 
180°C for two hours before use. Solutions of 100 mM CaCl2, 
100 mM MgCl2, and 75 mM LaCl3 were prepared in sterile water 
(Abbott Laboratories). 20 mM EGTA was prepared in HBSS, 
using 5.6% sodium bicarbonate (w/w) to adjust the pH to 
7.25. The calcium binding capacity of EGTA, as measured by 
its competitive ability to bind radioactive Ca2+, was not 
altered by the sterilization process. Ethylenediaminetetra- 
acetic acid, disodium (EDTA, Disodium Edetate Injection, 
Riker Labs) was diluted to 100 mM in sterile water. 
Heparin (Sodium Injection, Eli Lilly and Co.) 1000 u/ml 
and Polymyxin B (PMB, Aerosporin, Burroughs Wellcome Co.) 
50,000 u/ml were prepared in sterile saline. Epinephrine 
(EPI, Adrenalin, Parke-Davis) and propranolol hydrochloride 
(PROP, Inderal Injectable, Ayerst Labs) were stored as 1 
mg/ml solutions in sterile water. N6, 02 - dibutyryl 
adenosine 3', 5' - cyclic monophosphate monosodium salt (db- 
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cAMP, Sigma Chemical Co.) 1 mg/ml and Staphylococcal 
enterotoxin B (SE, Sigma Chemical Co.) 1 mg/ml were prepared 
in HBSS. Ionophore A23187 (Calbiochem) 2.0 mM and 
Prostaglandin E1 (PGEX, prost-13-en-l-oic acid, 11, 15 
dihydroxy-9-oxo-[11a, 13E, 15S], Sigma Chemical Co.) 1 mg/ml 
were prepared in 95% ethanol and stored at 0°C. 
Preparation and Incubation of Cells for EP Production 
Blood was collected into heparinized glass syringes from 
female 5-6 pound New Zealand White rabbits by cardiac 
puncture after anesthesia with intravenous sodium 
pentobarbital (75 mg in 1.5 ml) (Nembutal, Sodium Solution, 
Abbott Laboratories). In each experiment, blood from at 
least two donors was mixed and centrifuged at 1000 X g for 
fifteen minutes. The buffy coats were aspirated, 
resuspended in saline (for experiments in MEM) or HBSS, and 
washed twice. Total leukocytes were counted twice by 
hemocytometer, and differential counts were made on 200 
consecutive cells from Wright-Giemsa stained smears (mean 
%'s ± S.E. : lymphocytes 28.8 ± 3.0, granulocytes 61.6 ± 
3.2, monocytes 9.6 ± 0.4). Since monocytes are the only 
important source of EP in blood cells (21), the washed cells 
were divided into aliquots, each of which contained two to 
four doses of 2 X 106 monocytes mixed with other leukocytes. 
A standard pyrogenic dose of 100 pg/ml LPS was used in all 
experiments to stimulate EP production. 
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In some experiments, to test the effect of 
extracellular cations upon EP production, the incubation 
medium was altered by addition of CaCl2, MgCl2, LaCl3, EGTA, 
or EDTA. In other experiments, cells were preincubated with 
EGTA for up to three hours before the addition of LPS and/or 
cations. Some of these EGTA-preincubated cells were 
incubated further with added cations for up to three hours 
more before the addition of LPS. 
Ionophore A23187, db-cAMP, EPI, PROP, PGEj, and SE were 
incubated with cells alone, in combination, or with the 
addition of a standard dose of LPS to test their ability to 
stimulate EP production. In some experiments, PMB (200 
u/ml) was added to cell incubations to ascertain whether EP 
production was due to LPS contamination of potential 
activators (64). 
In one set of experiments (Ca2+ pulse), cells suspended 
in HBSS were incubated with A23187 for five minutes to allow 
incorporation of the ionophore into the cell membranes. 
CaCl2 and EGTA were then added to achieve a buffered free 
Ca2+ concentration, and incubation was continued for fifteen 
minutes. More EGTA was added before beginning the final 
incubation. This protocol allowed a transient (fifteen 
minute) pulse of ionized Ca2+ into the cells without 
requiring them to maintain such a high level of internal 
free Ca2+ over the extended incubation period. 
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After addition of all reagents, volumes were 
standardized so that each dose of 2 X 106 monocytes was 
suspended in a total volume of 2.5 ml. The cells were then 
incubated (5% C02 , 37°C) for 20 hours. The suspensions were 
cleared by centrifugation for ten minutes at 1000 X g, and 
the supernatants aspirated and assayed for EP. Cell 
viability, as measured by the ability of the pelleted cells 
to exclude eosin dye, was 75-90% in all experiments and was 
not reduced by any of the experimental agents. 
Assay of EP 
The EP content of supernatants was measured by intravenous 
injection into rabbits. The maximum elevation of 
temperature above baseline (fever) evoked within one hour, 
between 0.4 and 0.8°C, has been shown to be linearly related 
to the dosage of EP injected (65). The techniques used to 
record temperatures were those described by Atkins and Heijn 
(66), except that rectal temperatures were recorded 
continuously with a paper recorder (Rustrak TSC, Norwood, 
MA) . 
In most experiments rabbits received a dose of each 
supernatant in random order. Supernatants were stored at 
2 °C, but were allowed to warm to room temperature before 
injection. This enabled us to administer injections from a 
single experiment over a two to four day period without 
appreciable loss of pyrogenicity in the supernatants. 
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4 5Ca2 + Tracer Studies 
Cell Preparation 
In order to measure cell-associated 45Ca2+ after addition of 
ionophore A23187 or of LPS, relatively pure samples of 
monocytes were prepared using density gradients of Percoll 
or mixtures of Ficoll and Hypaque. 
Percoll separation technique. A two-step 
centrifugation procedure, based upon the one developed by 
Pertoft, et ad., (67) for isolating human blood monocytes, 
was used. Nine volumes of autoclaved commercial Percoll, a 
colloidal suspension of polyvinylpyrrolidone-coated silica 
particles averaging 15 - 30 nm in diameter (Pharmacia, 
Inc.), was added to one volume of 10X concentrate HBSS to 
make a stock solution of isotonic Percoll (SIP) with density 
1.124 g/ml. Heparinized rabbit blood was collected in the 
manner described above, and 28 ml were layered over 16 ml of 
60% (v/v) SIP in sterile saline, density 1.076 g/ml, and 
centrifuged for thirty minutes at 800 X g at room 
temperature. The interphase band, containing primarily 
mononuclear cells, was aspirated from each tube. The cells 
from two tubes were combined, suspended in a total volume of 
28 ml in sterile saline, and layered over 12 ml of 55% (v/v) 
SIP in sterile saline, density 1.070 g/ml. The cells were 
centrifuged for sixty minutes at 800 X g at 4°C, and the 
interphase bands were removed. It should be noted that no 
such interphase bands formed with the 50% (v/v) SIP solution 
used by Pertoft and colleagues for human cell separations. 
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Rather, all cells pelleted to the bottom following the 
second centrifugation. After washing the isolated cells 
twice in MEM, total and differential leukocyte counts were 
made (differential count mean %'s ± S.E.: lymphocytes 14.0 
± 4.4, granulocytes 2.5 ± 0.5, monocytes 78.5 ± 4.6). 
Ficol1-Hypaque separation technique. Despite the fact 
that the Percoll used was not contaminated with LPS, as 
measured by the Limulus Amebocyte Assay (68), cells isolated 
with Percoll produced EP without further stimulation. 
Therefore, a second cell separation technique was developed 
using density gradients of Ficoll 400, a synthetic polymer 
of sucrose and epichlorohydrin (Pharmacia, Inc.), and 
Hypaque, 3, 5 - diacetamido - 2, 4, 6 - triiodobenzoic acid 
(Hypaque Sodium 50%, Winthrop Laboratories Div., Sterling 
Drug, Inc.), in the place of Percoll. A stock solution of 
isotonic Ficol1-Hypaque (SFH), density 1.076 g/ml, was made 
by adding one volume of Hypaque to four volumes of a 7.9% 
(w/w) aqueous solution of Ficoll 400 which had been passed 
through a Nalgene filter (Nalgene Labware, Nalge Co.). From 
this stock solution three additional solutions were prepared 
and tested against each other for their suitability as 
separation media. Solution A was made by adding one volume 
of sterile saline to thirty seven volumes SFH; solution B 
by adding one volume saline to eighteen volumes SFH; and 
solution C by adding one volume saline to twelve volumes 
SFH. These solutions had densities of 1.074, 1.072, and 
1.070 g/ml, respectively. 
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Heparinized rabbit blood was obtained in the usual 
fashion, and diluted with an equal volume of sterile saline. 
28 ml of the diluted blood were layered over 16 ml SFH and 
centrifuged for thirty minutes at room temperature at a 
force of 800 X g. The mononuclear cells present in the 
interphase layer were collected, and total and differential 
leukocyte counts were made. The cells from two tubes were 
resuspended in a total volume of 28 ml with sterile saline, 
layered over 12 ml of solution A, B, or C, and centrifuged 
for sixty minutes at 4°C with a force of 800 X g. The 
interphase cells were collected, and total and differential 
leukocyte counts were again performed. The results, 
presented in Table 1, showed that solution C provided the 
purest preparation of monocytes, though with some sacrifice 
of yield. It was used, therefore, for subsequent 
experiments requiring monocyte-enriched samples. 
Ionophore Study 
Cells purified by Percoll separation were suspended in MEM 
in a concentration of 1.0 X 106 monocytes/ml. 0.8 ml 
aliquots of this suspension were incubated in a 37°C water 
bath with 0.1 ml of 4 5CaCl2 (86 mg Ca/ml, 1-9 mCi/ml, 
Radioactive Center, Amersham, England) that had been diluted 
1:100 with MEM, and 0.2 ml of a 2 mM solution of ionophore 
A23187 or of MEM (control). At timed intervals, 50 ul 




Cell Separations on Ficoll- Hypaque Gradients 
Total Differential Counts Total MNPC 
WBC' s y /o % y /o MNPC’s Yield 
Sample (X 108)+ PMN' s Lymph1 s MNPC' 's (X 108 ) (%) 
Whole 8.468 37 50 14 1.2 100 
Blood (.002) (3) (6) (4) ( .3) 
First 0.96 3 56 41 0.39 33 
Spin ( .02) (2) (4) (2) ( .02) (8) 
Second 
Spin 0.124 — 25 75 0.093 23 
(Soln A) (.005) (2) (2) (.004) (6) 
Second 
Spin 0.058 0.7 15 84 0.049 12 
(Soln B) (.002) ( .6) (4) (4) (.002) (3) 
Second 
Spin 0.067 1 6 93 0.062 16 
(Soln C) (.002) (1) (1) ( .002 ) (4) 




size filter (Type HA, Millipore Corp.). Each filter was 
immediately washed twice with 1 ml aliquots of ice cold MEM, 
and then placed in a scintillation vial with 4 ml of 
Hydrofluor (National Diagnostics). Total counts were 
measured by resuspending 50 ul of the unfiltered incubation 
medium in 4 ml of Hydrofluor. Each sample was counted for 
one minute on a scintillation counter (Model LS 3133P, 
Beckman Instruments). 
LPS Study 
Cells separated on Ficoll-Hypaque gradients were suspended 
in MEM in a concentration of 2.3 X 106 monocytes/ml. 0.9 ml 
aliquots were incubated in a 37°C water bath with 0.05 ml of 
the 45CaCl2 solution described above. After two hours, 100 
pg LPS and/or 500 u PMB were added in 0.1 ml MEM. 50 ul 
aliquots were removed at timed intervals and filtered, 
washed, and assayed, as above. 
Calculation of Free Calcium Concentration [Ca2 +] 
When Ca2+ and chelators were mixed in solution, the free 
calcium concentration [Ca2+] was calculated using the method 
of O'Sullivan to determine the "apparent" stability 
constants of chelate complexes at pH 7.30, the initial 
incubation pH, from the published "absolute" values of the 
constants (69). The calculated values for the stability 
constants were 3.98 X 107 M"1 for Ca-EDTA complexes, and 
1.896 X 107 M‘1 for Ca-EGTA complexes. 

RESULTS 
Effects of Free Calcium on EP Production 
Buffy coat cells were incubated with LPS in HBSS with or 
without added CaCl2. LPS stimulated EP production in all 
incubations, with Ca2+ concentrations up to 2.0 mM (Table 
2). The greatest response occurred with 0.5 mM CaCl2 in the 
incubation medium, but the responses in media containing 1.0 
mM or no added CaCl2 were not significantly lower, as 
measured by Student's t test for independent samples. 
Incubation with 2.0 mM CaCl2 added did significantly 
diminish the response seen following incubation with lower 
Ca2+ concentrations, as measured by Student's t test for 
paired samples. 
When other cells were incubated with LPS in an 
incubation medium prepared by diluting MEM 1:2 with sterile 
saline, EP was likewise produced despite the addition of 
CaCl2 or EDTA to alter the [Ca2+] (Table 3). The maximum EP 
production occurred with a calculated [Ca2+] of 0.4 mM, and 
it was significantly increased over production in media with 





Effect of Extracellular Calcium on EP Production in HBSS 
Mean fevers produced by supernatants from 2 X 106 monocytes 
incubated with 
concentrations 
or without LPS in HBSS with 
of CaCl2• 
various 
LPS [CaCl2] Fever (S.E.) Number of 






100 0 0.675 (.063)+ 4 
100 0.5 0.900 (.087) 3 
100 1.0 0.788 (.097)° 4 
100 2.0 0.363 (.080)+' ° 4 
o 
P<0.025 by paired t test 




Effect of Extracellular Calcium on EP Production in MEM 
Mean fevers produced by supernatants from 2 X 106 
monocytes incubated with 100 pg/ml LPS in MEM-saline solutions 











2.3 X 10'4 







+ Based on a total calcium concentration of 1.8 mM 
in MEM, and a resulting total calcium concentration of 
0.9 mM in our incubation medium which was MEM diluted 
1:2 with saline 
° 1.0 mM CaCl2 was added to this solution. 
There were four recipients for each supernatant. 
= P<0.025 by paired t test 
('++ p<0.005 by paired t test 
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Effects of EGTA Preincubation on Subsequent EP Production 
Cells were preincubated with 5 mM EGTA for 0-3 hours 
before the addition of LPS. Twenty hour supernatants were 
assayed for EP, and the mean fevers of EGTA-preincubated 
cells were expressed as percentages of the responses from 
cells activated with LPS without preincubation, after 
control responses (from cells incubated alone) were 
subtracted from both (Figure 3). The mean fever for cells 
not preincubated with EGTA was 0,80 ± 0.05°C (S.E.). 
Preincubation with EGTA resulted in substantial inhibition 
of LPS-stimulated EP production, and the degree of 
inhibition increased with prolongation of the preincubation 
period. Cells preincubated for three hours with EGTA 
released only 19% of the EP released by cells that had not 
been pretreated (mean fever 0.23 ± 0.04°C (S.E.)). 
Reversibility of EGTA Effects 
Inhibition of LPS-induced EP production by cells 
preincubated for three hours with 5 mM EGTA was partially 
reversed when 5 mM CaCl2 was added to the incubation medium 
simultaneously with LPS (Figure 4). EP production under 
these conditions was 53% of the amount produced, by cells not 
preincubated with EGTA. Lesser amounts of CaCl2 were not 
sufficient to restore EP production (Table 4). A second 
preincubation of cells with CaCl2 added to the incubation 
medium for up to three hours after the initial treatment 
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Figure 3: Effects of EGTA Preincubation on EP Production 
Mean fevers produced by supernatants from 2 X 106 monocytes 
incubated for twenty hours with 100 pg/ml LPS after 
preincubation of cells with 5 mM EGTA for 0-180 minutes, 
expressed as a percentage of the response seen when cells 
were not preincubated with EGTA. Numbers of recipients for 
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with EGTA before adding LPS did not affect the ultimate 
release of EP compared to that seen when CaCl2 and LPS were 
added together (Table 5). 
Substitution of 5 mM MgCl2 or LaCl3 for CaCl2 did not 
restore EP production following EGTA preincubation (Figure 
5). Further, incubation of cells with 0.1 mM MgCl2 or LaCl3 
for three hours after the initial treatment with EGTA 
prevented EP production when LPS and 5 mM CaCl2 were 
subsequently added. 
Effects of Ionophore A23187 on EP Production 
Cells were incubated for twenty hours with 0.20 uM A23187 in 
HBSS to which 25 uM CaCl2 or MgCl2 or both had been added. 
Under these conditions the ionophore did not stimulate EP 
production (Table 6). Cells incubated with both 0.20 uM 
A23187 and 100 pg/ml LPS released EP, though in amounts that 
were significantly lower than those produced in the absence 
of A23187 (P<0.05 by Student's t test for paired samples). 
In another set of experiments, we attempted to produce 
a pulse of intracellular calcium influx by incubating cells 
for five minutes in HBSS with 0.20 or 2.00 uM A23187, 
followed by the addition of Ca2+ and EGTA to produce 
buffered solutions with [Ca2+] of 0.37 or 2.3 uM. 
Incubations were continued for fifteen minutes, followed by 
the addition of either more EGTA in HBSS to reduce the 
[Ca2+] to 0.02 uM or more HBSS alone to keep the [Ca2+] 
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Figure 4: Reversibility of EGTA Effects with Calcium 
Mean fevers produced by supernatants from 2 X 106 monocytes 
preincubated with 5 mM EGTA for three hours before the 
addition of LPS (100 pg/ml) alone or with CaCl2/ expressed 
as a percentage of the response when cells were not 
pretreated with EGTA. Numbers of recipients for each 
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Calcium Concentration Required for Reversal of EGTA Effects 
Mean fevers produced by supernatants from 2 X IQ6 monocytes 
preincubated for three hours with 5 mM EGTA before the 
addition of 0.25 ng LPS and varying concentrations of 
















Time Course of Calcium Effects 
Mean fevers produced by supernatants from 2 X 106 monocytes 
preincubated for three hours with 5 mM EGTA, and then 
incubated with 5 mM CaCl2 for varying lengths of time before 
the addition of 0.25 ng LPS. There were four recipients for 
each supernatant. 
Time Incubated with CaCl2 














Figure 5: Specificity of the Calcium Effect 
Mean fevers produced by supernatants from 2 X 10s monocytes 
preincubated with 5 mM EGTA for three hours before the 
addition of 100 pg/ml LPS with or without the addition of 
CaCl2, MgCl2, or LaCl3 (5 mM). To two aliquots of cells, 
0.1 mM MgCl2 or LaCl3 was added after the EGTA 
preincubation, and cells were incubated for an additional 
three hours before the addition of LPS and 5 mM CaCl2. 
Numbers of recipients for each supernatant are given on each 












Effects of A23187 on Pyrogen Production 
Mean fevers produced by supernatants from 2 X 106 monocytes 
incubated with 0.20 uM A23187 and/or LPS in the presence of 
25 uM CaCl2 and/or MgCl2 in HBSS. There were four recipients 
for each supernatant. 
Potential Cations Fever (S.E 
Activator(s) Present (°C) 
None Ca2 + , Mg2 + 0 16 (0 01) 
A23187 Ca2 + 0 15 (0 02 ) 
A23187 Mg2 + 0 08 (0 04) 
A23187 Ca2 + , Mg2 + 0 14 (0 06) 
A23187 + LPS Ca2 + 0 31 (0 05) 
LPS — 0 68 (0 13 ) 
O P<0.05 by paired Student's t test 
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stable. Twenty hour supernatants did not show any EP 
activity, although an aliquot of the same cells incubated 
with LPS produced EP (mean fever 1.08°C; 2 recipients). 
4 5Ca2 + Tracer Study of Ionophore Action 
To confirm that added A23187 did interact with cells during 
incubation, rabbit mononuclear cells isolated on Percoll 
gradients were incubated with 45Ca2+ in the presence and 
absence of 0.36 uM A23187. Cells treated with ionophore 
showed an increase in cell-associated counts during the 
first thirty minutes of incubation, while the counts in 
untreated cells did not increase during a two hour 
incubation period (Figure 6). 
4 5Ca2 + Tracer Studies of LPS Stimulation 
Rabbit mononuclear cells isolated on Ficoll-Hypaque 
gradients were incubated with 45CaCl2 for two hours to allow 
equilibration before the addition of 100 pg/ml LPS and/or 
500 units PMB. No flux of Ca2+ could be demonstrated by 
changes in cell-associated 45Ca2+ upon the addition of LPS 
(data not shown). Separate aliquots of cells were incubated 
with or without LPS, and the twenty hour supernatants were 
assayed for EP. The aliquots incubated with LPS produced EP 
(mean fever 0.5°C; 2 recipients), while the aliquots without 
LPS were non-pyrogenic. 
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Figure 6: Ionophore-Induced Calcium Uptake in Monocytes 
Counts per minute of filtrates of 50 ul aliquots of cells 
incubated with (.) or without (o) 0.36 uM A23187, expressed 
as a percentage of the total counts in an unfiltered 50 ul 
aliquot. Total counts (standard errors) were 46043 (1284) 
for the cells incubated with ionophore and 57516 (7137) for 
the cells incubated alone. Standard errors are shown. 
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Effects of cAMP on EP Production 
Buffy coat cells incubated for twenty hours with 0.01 mg/ml 
EPI and/or 0.01 mg/ml PROP produced no detectable EP (Table 
7). Direct intravenous injection of these drugs at this 
dose produced no changes in baseline body temperature of 
test rabbits. To investigate the effects of EPI and PROP as 
modulators of an independently-stimulated response, cells 
were incubated with 100 pg/ml LPS with or without the 
addition of EPI and/or PROP (0.01 mg/ml). These drugs did 
not affect the response of monocytes to LPS (Table 8). 
Similarly, we found that 14 uM PGEX did not affect LPS 
stimulation of EP production (Table 8). 
10 ug/ml SE stimulated release of EP sufficient to 
cause a mean fever of 0.78 ± 0.18°C, but the addition of 200 
units/ml PMB before incubation abolished the effect. 
Similarly, supernatants from cells incubated with 3 mM db- 
cAMP produced fevers of 0.47 ± 0.11°C, but this was 
prevented by including 200 units/ml PMB in the incubation 
medium (Table 9). Because of the presumed presence of LPS 
contaminating these agents, direct testing of their ability 
to augment LPS-stimulated release of EP was not practical. 
However, they clearly did not prevent the release of EP. 

TABLE 7 
Effects of Epinephrine and Propranolol on EP Production 
Mean fevers produced by supernatants from 2 X 106 monocyte 
incubated with 0.01 mg/ml EPI and/or 0.01 mg/ml PROP alone 
or in the presence of 100 pg/ml LPS. Except where noted, 
there were four recipients for each supernatant. 
Potential Fever (S.E.) 
Acti vator(s) ( °C) 







EPI + PROP o- 
LPS 0. . 86 (0. 10) 
LPS + EPI 0. . 84 (0. 09) = 
LPS + PROP 0. . 73 (0. 15) = 
LPS + EPI + PROP 0 . . 76 (0. 10) = 
+ There were five recipients for this supernatant. 
° There were three recipients for this supernatant. 
” There were two recipients for this supernatant. 
= Not significantly different from fever when cells 
were incubated with LPS alone, by Student's t test 
for paired samples 

TABLE 8 
Effects of Prostaglandin E1 on EP Production 
Mean fevers produced by supernatants from 2 X 106 monocyte 
incubated with 14 uM PGEi, alone or in the presence of LPS 














+ There were two recipients for this supernatant. 





Pyrogenicity of SE and db-cAMP due to LPS Contamination 
Mean fevers produced by supernatants from 2 X 106 monocytes 
incubated with 10 ug/ml SE or 3 mM db-cAMP, alone or in the 





SE + PMB 
db-cAMP 
db-cAMP + PMB 
Fevers (S.E.) 
(°< -) 
0. . 05 (0 . 05 ) + 
0 . , 78 (0 . 18) ° 
0. . 03 (0 . 03 ) ' 
0. . 47 (0 .11)° 
0. . 03 (0 . 03 ) ° 
+ There were two recipients for this supernatant. 
° There were six recipients for this supernatant. 
' Significantly different by Student's t test for 
independent samples (P<0.025) 
= There were three recipients for this supernatant 
( Significantly different by Student's t test for 
independent samples (P<0.025) 

DISCUSSION 
The Role of Calcium in EP Production 
Using a standard dose of LPS as a pyrogenic stimulus we 
found that rabbit blood monocytes can produce EP in media 
with free calcium concentrations calculated to be in the 
10'8 to 10'3 M range. As in studies reported by Wood and 
colleagues (48-50), we found that EP production was 
inhibited at greater than physiological concentrations of 
free calcium. Studies of macrophage lysosomal enzyme 
release stimulated by incubation with zymosan have also 
shown that extracellular Ca2+ is not required, and that high 
levels of extracellular Ca2+ (5mM) inhibited enzyme release 
(54). That we saw more inhibition in HBSS than in MEM can 
be attributed to calcium-binding components in the latter 
medium, notably succinic acid and the amino acids present, 
which reduce the concentration of free calcium. MEM also 
contains more phosphate and sulfate anions, which complex 
with calcium, as well. In both media, however, we found 
maximal EP production with a calculated free [Ca2+] of 0.4 - 
0.5 mM. This is lower than the average value of 1.15 mM 
free Ca2+ Moore measured in the serum of normal volunteers 
(70). Although all buffy coat preparations were washed 




of Ca2+ as a trace contaminant), significant amounts of Ca2+ 
may have remained bound to cell membranes. This would 
increase the actual amount of Ca2+ present and, perhaps, 
raise the local concentration of free Ca2+, in addition. 
The fall in pH seen during the course of incubation, to as 
low as 6.9, would increase free Ca2+ further by decreasing 
the stability of calcium complexes. In our HBSS 
incubations, the difference in fever stimulated by EP 
generated with 0.5 and 1.0 mM free calcium was not 
statistically significant (P>0.05 by Student's t test for 
paired samples), and no comparable incubation with 1 mM free 
Ca2+ was performed in MEM. Therefore, we cannot exclude the 
possibility that EP production is maximal at approximately 
physiological concentrations of free Ca2+. 
While monocytes could be stimulated to produce 
submaximal amounts of EP with extremely low levels of free 
extracellular Ca2+, preincubation of cells with a Ca2+ 
chelator inhibited subsequent stimulation of EP production. 
The degree of inhibition was related to the time of 
preincubation. It was partially reversed by later addition 
of Ca2+, but not other cations, to the system. In fact, 
incubation with small amounts of Mg2+ or La3 + prevented the 
reversal of inhibition by later addition of Ca2+. The 
prolonged incubation of cells depleted of Ca2+ during these 
experiments may have had other effects which prevented 
subsequent stimulation, although in the experiments 
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summarized in Table 5 there was no evidence that delayed 
addition of LPS to cells reduced the amount of EP produced. 
These results suggest that the mere presence of Ca2+ in the 
extracellular space where it would be available to fulfill 
any required role in the binding of LPS to the cell membrane 
was not sufficient to cause EP production, and that re-entry 
of Ca2+ into the cells was necessary for EP production to 
occur. 
While the role of extracellular Ca2+ in biological 
systems can be difficult to determine (71), these 
observations suggest that there is a pool of intracellular 
Ca2+ important to the process of pyrogenic stimulation 
and/or EP production which is somehow protected from rapid 
equilibration with extracellular Ca2+. It may be analagous 
to the intracellular pool thought to play a role in 
pancreatic acinar cell secretion of enzymes (72). This pool 
may be bound to the plasma membrane, or may be sequestered 
in another intracellular site, such as the mitochondria or 
endoplasmic reticulum. Figure 7 is a simplified schematic 
diagram of calcium compartments in the macrophage. 
Macrophages have a membrane-bound Mg2+ and ATP dependent 
Ca2+ pump which transports free Ca2+ from the cytoplasm to 
the extracellular surface (73), and over time the action of 
this pump could deplete the intracellular stores of Ca2+ if 
reentry is prevented by formation of EGTA-Ca complexes 
extracellularly. Borle has shown that mitochondria lose 
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Ca2+ slowly with a half-time of 152 minutes (74), while Mela 
and Chance have shown that mitochondrial Ca2+ uptake has a 
half-time of 8 seconds (75). These observations are 
consistent with our results showing that a lengthy 
preincubation with EGTA is required to deplete the necessary 
Ca2+ pool, but that the pool is replenished rapidly as 
evident by restoration of the response when Ca2+ is added 
together with the pyrogenic stimulus. 
In some systems where calcium is thought to be 
important in stimulus-secretion coupling, Ca2+ ionophores 
have been used to elicit a response in the place of a normal 
stimulus. Their action is thought to be due to increasing 
intracellular Ca2+ levels. For example, ionophore A23187 
has been shown to stimulate the release of histamine from 
mast cells (76) and the release of catecholamines from 
adrenal medulla (77). A23187 has also been reported to 
stimulate the release of platelet activating factor from 
rabbit, rat, and human alveolar macrophages (78). We found 
that A23187, in doses that allowed influx of a radioactive 
Ca2+ tracer, was not a sufficient stimulus for EP production 
by rabbit monocytes. Similarly, Foreman, et a_l. , reported 
that A23187 did not stimulate lysosomal enzyme secretion by 
macrophages (55), and MacMillan and his associates found 
that A23187-induced release of the lysosomal acid hydrolase 
B-N-acetyl-glucosaminidase from macrophages was accompanied 
by the release of lactate dehydrogenase, a cytosolic enzyme. 
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Figure 7: Calcium Metabolism in the MNPC 
Schematic diagram of the calcium compartments within 
(modified from 53). Ca2+e = free extracellular Ca2+, 
bound extracellular Ca2+, Ca2+c = free cytosolic Ca2+ 
= bound cytosolic Ca2+, Ca2+m = free mitochondrial Ca 
























signifying the loss of cell integrity (54). Our observation 
that EP production induced by LPS was reduced in the 
presence of A23187 may have been due to a similar toxic 
effect of the ionophore on monocytes. Alternatively, the 
presence of ionophore and a low Ca2+ extracellular medium 
may have caused depletion of intracellular stores of Ca2+ as 
cells were stimulated by LPS and released their 
intracellular pools. Hand and co-workers reported that 
incubation of alveolar macrophages with A23187 resulted in a 
rise in intracellular acid phosphatase and an increased rate 
of intracellular bactericidal activity, but only after 40 to 
72 hours of incubation, and only in the presence of mM Mg2+ 
(56). We found that Mg2+, like Ca2+, was ineffective in 
stimulating EP production with A23187. Since detectable EP 
is released in the first two to three hours after 
stimulation of the monocyte (79), it is unlikely that 
prolonging incubations would yield a different result. 
While we were unable to demonstrate either influx or 
efflux of 45Ca2+ from LPS-stimulated monocytes, this does 
not exclude the possibility that transient rises of free 
cytoplasmic Ca2+ occur during stimulation on a time scale 
which is shorter than the one we observed. Changes in 
plasma membrane permeability allowing influx of Ca2+ that 
were matched by increased activity of the membrane-bound 
Ca2+ pump, or release of intracellular stores with rapid re¬ 
uptake would not necessarily cause changes in cell- 
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associated Ca2+ observable in our experiments. This would 
require a system in which intracellular Ca2+ was very 
tightly controlled. The lack of increase in cell-associated 
Ca2+ during stimulation is consistent with the observation 
of Wood that cells secreting EP had lower total Ca2+ levels 
than cells in which secretion had been suppressed (50). 
The Role of Cyclic Nucleotides in EP Production 
Adenosine 3', 5' cyclic monophosphate (cAMP) has been 
reported to inhibit macrophage migration (57), to decrease 
secretion of plasminogen activator by mouse exudate cells 
(58) and a macrophage-like tumor cell line (J774.2) (59), 
and to decrease the secretion of lysosomal enzymes by mouse 
exudate cells (54). cAMP has also been reported to 
stimulate secretion of T-cell activating factors from J774.2 
cells, suggesting that it might be the second messenger 
involved in LPS-stimulated release of such factors from 
MNPC's (80), and in later experiments both cAMP and LPS were 
shown to induce phosphorylation of non-histone proteins by 
these cells (81). However, no attempts were made to exclude 
the possibility that the analogues of cAMP used may have 
been contaminated with LPS, and that all of the effects seen 
were LPS-induced. For example, LPS reduces plasminogen 




We found that db-cAMP, which is more resistant to 
phosphodiesterase degradation and crosses cell membranes 
more readily than CAMP, did not stimulate EP production in 
the presence of polymyxin B (PMB), an antibiotic which 
blocks the pyrogenicity of LPS ini vitro (64). Further, 
epinephrine and prostaglandin Ex, in doses greater than 
those needed to stimulate adenylate cyclase maximally in 
macrophage homogenates (60) or in intact cells (54, 83), 
failed to stimulate EP production or to alter EP production 
in response to a standard dose of LPS. Staphylococcal 
enterotoxin B, another agent thought to activate adenylate 
cyclase, did not generate EP in the presence of PMB, 
confirming earlier observations that it did not stimulate EP 
production in vitro (84). 
Duff performed a parallel set of experiments in our 
laboratory to investigate the role of guanosine 3', 5' 
cyclic monophosphate (cGMP) in EP production. His results, 
summarized in Table 10, show that incubation of cells with 
phorbol myristic acid (PMA), an agent which stimulates 
endogenous cGMP production, in a concentration of 100 ng/ml 
for 24 or 48 hours did not cause EP production (85). This 
concentration of PMA was active, however, in stimulating the 
metabolic burst in neutrophils and monocytes. Others have 
found that PMA does not activate macrophages unless LPS is 




Effects of cGMP on EP Production 
Mean fevers produced by supernatants from 2 x 106 monocytes 
incubated with 1 mM b-cGMP, 1 mM IBMX, or 100 ng/ml PMA with 
or without 500 units/ml PMB (from 85). 
Potential Fevers (S.E) 
Activator(s) (°C) 
PMA (24 hour incubation) 0.13 (0.03) 
PMA (48 hour incubation) 0.13 (0.01) 
b-cGMP 1.17 (0.12) 
b-cGMP + PMB 0.18 (0.06) 
IBMX 0.40 (0.08) 
IBMX + PMB 0.07 (0.02) 
IBMX + PMB + b-cGMP 0.08 (0.04) 
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Further, Duff found that 1 mM 8-bromo-guanosine 3’, 5' 
cyclic monophosphate (b-cGMP) stimulated production of EP by 
cells, but this was suppressed by addition of 200 units/ml 
PMB during incubation. Similar results were obtained with 1 
mM IBMX, a phosphodiesterase inhibitor, with and without the 
addition of b-cGMP (Table 10). Since the b-cGMP and IBMX 
used were contaminated with LPS, it was not possible to 
investigate their effects on EP production independently- 
stimulated by LPS. However, there is an earlier brief 
report that IBMX does not affect LPS-stimulated EP 
production (63). 
The Second Messenger Hypothesis 
With the discovery that many diverse hormones stimulated 
responses in target cells by the common pathway of 
increasing intracellular cAMP levels, Sutherland and his 
colleagues proposed a set of four criteria to establish the 
presence of such a second messenger in a given system (87). 
These criteria can be restated in a more general fashion to 
encompass other potential second messengers, such as Ca2+ or 
cGMP. First, a membrane-bound entity which responds to the 
first messenger (cell stimulator) by generation of the 
second messenger should be demonstrated. Second, the level 
of the second messenger within the cell should change 
appropriately with stimulation by the first messenger. 
Third, the effect of the first messenger (cell response) 
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should be enhanced by agents which inhibit clearance of the 
second messenger, if the target cell is not already 
maximally stimulated. Fourth, exogenous addition of the 
proposed second messenger should reproduce the action of the 
first messenger. 
In the experiments reported here, we have shown that 
Ca2+, cAMP, and cGMP cannot fulfill these criteria, and, 
therefore, they should not be considered second messengers 
for LPS-stimulated EP production by MNPC's. While there is 
a role for Ca2+ in this process, as evidenced by the 
reversible inhibition of EP production by prolonged 
chelation with EGTA, addition of extracellular Ca2+ or 
ionophore A23187 to increase the intracellular level of Ca2+ 
was not sufficient to stimulate EP production. Further, 
MNPC's stimulated with LPS failed to demonstrate calcium 
uptake, suggesting that an influx of extracellular Ca2+ is 
not important to the process. Addition of exogenous db-cAMP 
or agents shown to stimulate cAMP generation in MNPC's were 
also not sufficient to initiate EP production. Nor did they 
enhance or inhibit EP production from cells submaximally 
stimulated with LPS. Similarly, Duff's experiments show 
that exogenous b-cGMP and PMA, an agent which stimulates 
endogenous generation of c-GMP, do not stimulate EP 
production in the absence of LPS. 

PROSPECTS FOR FUTURE WORK 
Except for the poorly-defined role of Ca2 + in this system, 
the mechanism of derepression of the EP genome in MNPC's 
remains unclear. Our work suggests that an intracellular 
pool of Ca2+ is important to the process, but no release of 
intracellular stores could be demonstrated by measuring Ca2+ 
efflux with a radioactive tracer. Recent evidence indicates 
that Dantrolene Sodium, an agent used to treat malignant 
hyperthermia, may act by preventing Ca2+ release from the 
sarcoplasmic reticulum in muscle cells (88), and that it may 
similarly prevent release of intracellular stores from other 
tissues, such as adrenal medulla (89) and pancreatic islet 
cells (90). If Dantrolene can be shown to inhibit LPS 
stimulation of EP production, the intracellular release of 
Ca2+ as a step in the process would be more plausible. 
It is possible that another second messenger will be 
revealed in future work. Intracellular Na+, as suggested by 
Wood and his associates (48, 49), may prove to be important. 
There is some evidence that Na+ may play such a role in 
pancreatic acinar cell secretion (reviewed in 91). While it 
is possible that the effect of LPS is a direct one, not 
requiring the existence of a second messenger to interact 




(81), the broad diversity of agents which can stimulate EP 
production makes this less likely. 
Since this work was begun, others have shown the 
existence of calcium-dependent protein kinases in a variety 
of tissues (92). While they do not require cyclic 
nucleotides for activity, phospholipids and some of their 
breakdown products have a marked effect. While 10"3 M - 
10"4 M Ca2 + is needed to activate the kinases in the absence 
of phospholipid, 10"6 M Ca2+ is sufficient in the presence 
of phophatidylinositol (PI), phosphatidyl serine (PS), and 
diacylglycerols (92, 93). Thus, under proper circumstances, 
these Ca2+-dependent kinases can be activated with normal 
cytosolic concentrations of ionized Ca2+. There has long 
been speculation that PI metabolism is an important step in 
cell activation, since activators of many types of cells 
increase rates of PI turnover in the cell membrane (94). 
Karnovsky and his colleagues have shown that LPS induces an 
increase in incorporation of inorganic phophate into 
monocyte membrane lipids, particularly into PI and PS (95). 
They have shown, further, that this process requires Ca2+. 
Thus, one can put these observations into a hypothesis 
of monocyte activation which begins with binding of LPS or 
another agent to the cell surface, thereby inducing a 
breakdown of PI in the membrane. The PI breakdown products 
subsequently released into the cytosol might activate a 
protein kinase which requires small amounts of calcium, such 

52 
as already exist in the cytosol. Thus, consistent with our 
results, no influx of calcium would be required, and no 
significant release of intracellular stores, with consequent 
net efflux of calcium from the cell, would be necessary 
either. Such an activated protein kinase could then 
phosphorylate a histone or other controller of DNA 
expression to derepress the EP genome. The inhibitory 
effect of corticosteroids on EP production may be exerted 
through effects on PI metabolism, a hypothesis which could 
be tested by trying to duplicate Karnovsky's results in the 
presence of steroids. 
Given the widespread ability of most vertebrates to 
produce EP and the potent role it plays as a controller of 
immune function, further work to define the mechanism of EP 
production should be undertaken. 
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